We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+15.18%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$4.02B
(+9.6%)
Cap. Flow
-$2.06B
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
19.65%
Holding
934
New
52
Increased
488
Reduced
320
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$191M |
| 2 |
Microsoft
MSFT
|
+$169M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$162M |
| 4 |
Netflix
NFLX
|
+$126M |
| 5 |
Philip Morris
PM
|
+$87.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$231M |
| 2 |
Banco Bradesco
BBD
|
+$182M |
| 3 |
Amdocs
DOX
|
+$175M |
| 4 |
Oracle
ORCL
|
+$156M |
| 5 |
Chevron
CVX
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.39% |
| 2 | Technology | 14.48% |
| 3 | Consumer Discretionary | 13.41% |
| 4 | Healthcare | 10.59% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Conagra Brands
CAG
$7.07B
| $7.9M | 0.02% |
284,855
+85,396
| +43% | +$1.96M |
|
552
Idexx Laboratories
IDXX
$42.9B
| $7.75M | 0.02% |
34,658
+9,732
| +39% | +$2.01M |
|
553
Vulcan Materials
VMC
$36.3B
| $7.7M | 0.02% |
65,043
+17,488
| +37% | +$1.89M |
|
554
EPAM Systems
EPAM
$4.69B
| $7.63M | 0.02% |
45,103
-10,612
| -19% | -$1.59M |
|
555
Orion
OEC
$394M
| $7.6M | 0.02% |
400,000
| – | – |
|
556
Arthur J. Gallagher & Co
AJG
$63.7B
| $7.49M | 0.02% |
95,933
+23,775
| +33% | +$1.83M |
|
557
McCormick & Company Non-Voting
MKC
$13.4B
| $7.42M | 0.02% |
98,472
+35,296
| +56% | +$2.38M |
|
558
ManpowerGroup
MAN
$2.39B
| $7.35M | 0.02% |
88,875
+6,841
| +8% | +$539K |
|
559
Cadence Design Systems
CDNS
$90B
| $7.27M | 0.02% |
114,410
+39,501
| +53% | +$2.09M |
|
560
Mettler-Toledo International
MTD
$26.8B
| $7.22M | 0.02% |
9,988
+3,516
| +54% | +$2.29M |
|
561
Nektar Therapeutics
NKTR
$2.39B
| $7.2M | 0.02% |
14,275
-686
| -5% | -$407K |
|
562
Quest Diagnostics
DGX
$25.1B
| $7.18M | 0.02% |
79,841
+20,435
| +34% | +$1.77M |
|
563
Lincoln National
LNC
$7.91B
| $7.08M | 0.02% |
120,658
+35,095
| +41% | +$2.08M |
|
564
SEI Investments
SEIC
$11.9B
| $6.94M | 0.02% |
132,831
+80,174
| +152% | +$4.01M |
|
565
Warrior Met Coal
HCC
$4.23B
| $6.93M | 0.02% |
+228,104
| New | +$6.24M |
|
566
D.R. Horton
DHI
$41B
| $6.92M | 0.02% |
167,259
+53,551
| +47% | +$2.1M |
|
567
Synopsys
SNPS
$71.5B
| $6.91M | 0.02% |
60,012
+19,916
| +50% | +$1.97M |
|
568
C.H. Robinson
CHRW
$22B
| $6.89M | 0.01% |
79,131
+18,666
| +31% | +$1.64M |
|
569
MSCI
MSCI
$40B
| $6.88M | 0.01% |
34,617
+11,815
| +52% | +$2.06M |
|
570
Everest Group
EG
$15.2B
| $6.76M | 0.01% |
31,299
-50,853
| -62% | -$11.1M |
|
571
T-Mobile US
TMUS
$193B
| $6.76M | 0.01% |
97,771
+21,319
| +28% | +$1.49M |
|
572
Arista Networks
ANET
$219B
| $6.73M | 0.01% |
342,544
+121,872
| +55% | +$1.93M |
|
|
CIT
573
DELISTED
CIT Group Inc.
CIT
| $6.69M | 0.01% |
139,520
-14,115
| -9% | -$664K |
|
|
WCG
574
DELISTED
Wellcare Health Plans, Inc.
WCG
| $6.61M | 0.01% |
24,513
+5,722
| +30% | +$1.48M |
|
575
Skyworks Solutions
SWKS
$9.06B
| $6.6M | 0.01% |
80,048
+24,925
| +45% | +$1.92M |
|
Similar funds
Aberdeen Group's Q1 2019 Portfolio in Review
As of Q1 2019, Aberdeen Group held 934 positions worth $46.2B, up 9.6% from $42.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Aberdeen Group withdrew a net $2.06B in Q1 2019, closing 33 positions and reducing 320 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Linde worth $203M.
- Aberdeen Group's largest Q1 2019 buy was Linde: 1,152,668 shares worth $203M.
- Aberdeen Group added most to Microsoft in Q1 2019, an estimated $169M increase.
- Aberdeen Group's biggest Q1 2019 reduction was Pfizer, cutting an estimated $231M.
- Aberdeen Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $36M.
- Aberdeen Group's ten largest holdings make up 20% of its $46.2B portfolio in Q1 2019.
- Aberdeen Group opened 52 new positions and closed 33 in Q1 2019.
- Aberdeen Group's portfolio value rose 9.6% quarter-over-quarter to $46.2B.
Based on Aberdeen Group's 13F filing for Q1 2019, filed 14 May 2019.